Cancer treatment-related cardiovascular toxicity according to the ESC definition in patients receiving CAR T-cell therapy [0.03%]
根据ESC定义的CAR-T治疗患者的心血管毒性
Jakob Christoph Voran,Carolin Richard,Astrid Dempfle et al.
Jakob Christoph Voran et al.
Background: Chimeric antigen receptor (CAR) T-cell therapy has substantially improved outcomes in refractory hematologic malignancies but may cause cardiovascular complications, particularly in the context of cytokine rel...
ICU-onset atrial fibrillation surrogate, thrombocytopenia, and short-term outcomes in patients with cancer requiring intensive care: a retrospective ICU cohort study [0.03%]
一项回顾性重症监护队列研究：血小板减少作为癌症患者的院内心房纤颤标志与短期结局的关系
Hasan Burak Isleyen,Sevil Tugrul Yavuz,Sercan Bulut et al.
Hasan Burak Isleyen et al.
Background: Cancer and atrial fibrillation frequently coexist. Intensive care adds hemodynamic stress, organ failure, and competing bleeding risk. Whether platelet-defined thrombocytopenia modifies the association between...
Interpretable machine learning for cardiovascular disease risk prediction in cancer survivors: development and internal validation [0.03%]
癌症幸存者心血管疾病风险预测的解释型机器学习方法的发展与内部验证
Guoxing Zhang,Xueying Zhang,Chunyi Jia et al.
Guoxing Zhang et al.
Background: Cardiovascular disease (CVD) is a major concern among cancer survivors. However, the intersection of cancer and CVD has only recently gained broader attention, and substantial evidence gaps remain. This study ...
No detectable early subclinical cardiotoxicity within 12 weeks of thoracic radiotherapy under predominantly low cardiac dose exposure: a prospective cohort study [0.03%]
胸部放疗早期（放射性心脏剂量较低）无亚临床心毒性的证据：一项前瞻性队列研究
Iván Valdés-Orrego,Francisco Acevedo,Tomas Merino
Iván Valdés-Orrego
Background: Early radiation-induced cardiac injury in patients receiving thoracic radiotherapy (RT) remains insufficiently characterized. Global longitudinal strain (GLS) and circulating biomarkers such as high-sensitivit...
The risk of myocardial infarction and ischemic stroke in pelvic cancer surgery [0.03%]
盆腔癌手术中心肌梗死和缺血性卒中的风险
Nicola Giudici,Johan Björklund,Renata Zelic et al.
Nicola Giudici et al.
Background: Myocardial infarction and ischemic stroke are common causes of morbidity after major cancer surgery. Understanding the risks associated with both open and laparoscopic surgery is crucial in reducing postoperat...
Mortality predictors in cancer patients undergoing transcatheter aortic valve implantation for aortic stenosis: a systematic review and meta-analysis [0.03%]
癌症患者接受经导管主动脉瓣植入术治疗主动脉瓣狭窄的预后因素：系统评价和meta分析
Azin Alizadehasl,Yasamin Afsari Zonooz,Golnar Mortaz Hejri et al.
Azin Alizadehasl et al.
Background: The coexistence of cancer and aortic stenosis is increasingly common in elderly patients, presenting unique challenges for management. Transcatheter aortic valve implantation (TAVI) offers a less invasive alte...
Correction: Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement [0.03%]
关于癌症成人患者心血管疾病预防和管理的更正：国际心脏肿瘤学会（IC-OS）与多国抗癌支持治疗协会（MASCC）临床实践声明
Susan Dent,Michelle B Nadler,Anne Blaes et al.
Susan Dent et al.
Published Erratum
Cardio-oncology (London, England). 2026 Jul 10;12(1):88. DOI:10.1186/s40959-026-00533-8 2026
Burden of cardiovascular diseases in breast cancer survivors: a 9-year retrospective cohort study based on regional medical data in Inner Mongolia China [0.03%]
内蒙古乳腺癌幸存者心血管疾病负担的回顾性队列研究
Qiaorui Wen,Yunjing Zhang,Liying Qiao et al.
Qiaorui Wen et al.
Background: Breast cancer (BC) and cardiovascular diseases (CVD) shared many risk factors. Hitherto no studies revealing the burden of CVD and its subtypes in mainland Chinese BC patients exist. This study aimed to descri...
Chimeric antigen receptor T cell therapy cardiotoxicity: a narrative review [0.03%]
嵌合抗原受体T细胞治疗心肌毒性：综述
G Sinigiani,G Scapinello,T Berno et al.
G Sinigiani et al.
Chimeric antigen receptor (CAR) T cell therapy has transformed the management of some relapsed/refractory hematologic malignancies. However, cardiovascular (CV) toxicity has emerged as a clinically relevant concern, particularly given its i...
Temporal dynamics of cardiac biomarkers in therapy‑related cardiotoxicity: a prospective cardio‑oncology cohort study [0.03%]
心脏毒性的生物标志物的时间动态：一项心肿瘤学队列研究
Lidia Anca Kajanto,Dana Lucia Stănculeanu,Anca Chisoi et al.
Lidia Anca Kajanto et al.
Background: Cardiotoxicity associated with antineoplastic therapies remains an important clinical challenge in modern oncology. Early identification of subclinical cardiac injury may improve cardiovascular surveillance an...